AbCellera Biologics (ABCL) Goodwill (2020 - 2026)

AbCellera Biologics (ABCL) has 7 years of Goodwill data on file, last reported at $47.8 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.8 million (changed 0.0% YoY) and the FY2025 annual result came in at $47.8 million, changed 0.0% from the prior year.
• Goodwill steadied at $47.8 million in Q1 2026, from $47.8 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $47.8 million in Q1 2022 to a low of $47.8 million in Q1 2022.
• A 5-year average of $47.8 million and a median of $47.8 million in 2022 frame the typical range for Goodwill.
• The widest YoY moves for Goodwill: up 193.18% in 2022, down 3.34% in 2022.
• Tracing ABCL's Goodwill over 5 years: stood at $47.8 million in 2022, then changed by 0.0% to $47.8 million in 2023, then changed by 0.0% to $47.8 million in 2024, then changed by 0.0% to $47.8 million in 2025, then changed by 0.0% to $47.8 million in 2026.
• The last three Goodwill figures came in at $47.8 million (Q1 2026), $47.8 million (Q4 2025), and $47.8 million (Q3 2025), per Business Quant data.